Physician profile
Jean Katow
NPI 1831260090
$1,801.99
in general payments reported to CMS, 2019-2025
20 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $195 · 2021: $213 · 2022: $150 · 2023: $327 · 2024: $252 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $224.69 | 2020-2024 | Kcentra |
| Bausch & Lomb Americas INC. | $174.10 | 2023-2024 | Vyzulta, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $174.09 | 2019-2020 | |
| Amarin Pharma, INC. | $140.00 | 2019 | |
| Allergan, INC. | $129.95 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.98 | 2025 | Xifaxan |
| Eisai INC. | $121.65 | 2019 | |
| Alexion Pharmaceuticals, INC. | $117.93 | 2019 | |
| Alcon Vision LLC | $115.92 | 2022-2024 | Rocklatan, Argos |
| Aerie Pharmaceuticals, INC. | $87.03 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $79.16 | 2021-2023 | Cequa |
| Horizon Therapeutics Plc | $67.51 | 2022-2023 | Tepezza |
| Thea Pharma INC. | $64.20 | 2023 | Iyuzeh |
| Abbvie INC. | $50.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.19 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $32.24 | 2023 | Acthar |
| Oyster Point Pharma, INC. | $27.84 | 2024 | Tyrvaya |
| Akorn Operating Company LLC | $14.79 | 2021 | |
| Akorn, INC. | $10.86 | 2019 | |
| Alimera Sciences, INC. | $6.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Katow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.